AzTrials
AzTrials

ElderlyCHUTENCT02862379

Personalized Rehabilitation Program for Elderly Patients That Fall

A study testing home-based program in people with Elderly and Falls, run by Lille Catholic University at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The risk of falling affects more than one third of people over 65 years old and over 50% of persons over 80 years. These falls have important consequences for the autonomy of the elderly patient and also increase the risk of sequelae and death. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Elderly, Falls, Rehabilitation
What is being tested?
home-based program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteFrance
Study dates
Oct 2014to Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Persons who have fallen minimum twice the last year
  • 60 years old or more
  • Mini Mental State Examination (MMSE) equal or superior to 23/30
  • Persons who gave consent to participate in the study
  • Persons with severe visual or hearing impairment

Who cannot join

  • Patients with severe disease that might interfere with walking or with program monitoring

Trial locations and contacts

1 site in 1 country.

France1 site
  • Esprad Chute, Ghicl

    Lomme, 59462

Other trials in France

About this study

Official title: Evaluation of a Personalized Rehabilitation Program for Elderly Patients That Fall : Impact on the Fear of Falling

The risk of falling affects more than one third of people over 65 years old and over 50% of persons over 80 years. These falls have important consequences for the autonomy of the elderly patient and also increase the risk of sequelae and death.

The goal of this study is to evaluate a personalized rehabilitation program for elderly patients that fall for the first time and to measure the impact on the fear of falling of these patients. This intervention is a home-based program combining exercises, home modifications and education on fall risk factors.

Being tested
home-based program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • home-based programBehavioural

    The objective of the rehabilitation program is to reduce the risk of falls after management of the risk factors identified. This intervention is a home-based program combining exercises, home modifications and education on fall risk factors

Study groups in NCT02862379
Study groupRoleWhat they receive
Elderly patients that fallExperimentalPersonalized rehabilitation program for elderly patients that fall for the first time. This intervention is a home-based program combining exercises, home modifications and education on fall risk factors.
Receives: Behavioral: home-based program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Falls Efficacy Scale (FES-I)

    The FES is a 10-item validated questionnaire that can be self-administered or completed during an interview. The person is asked to indicate on a 10-level rating scale his/her level of confidence in his/her capacity to accomplish a variety of activities of daily life (e.g., going up and down the stairs, taking a bath or shower) without falling. A FES score is calculated by adding up the score of each item.

    Measured: Change from baseline at 6 months and 12 months

Secondary outcomes (8)
  1. Number of falls the previous year before inclusion

    Measured: at baseline

  2. Life Space Assessment scale

    Measured: Change from baseline at 6 months and 12 months

  3. Get up and go test

    It uses the time that a person takes to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down. During the test, the person is expected to wear their regular footwear and use any mobility aids that they would normally require

    Measured: Change from baseline at 6 months and 12 months

  4. Walking and talking test

    Measured: Change from baseline at 6 months and 12 months

  5. Tinetti test

    It is a clinical test for assessing a person's static and dynamic balance abilities

    Measured: Change from baseline at 6 months and 12 months

  6. Measure of the time that the patient is able to stay in station bipedal standing feet together followed by a monopodal support

    Measured: Change from baseline at 6 months and 12 months

  7. EuroQol five dimensions questionnaire (EQ-5D)

    Questionnaire about quality of life

    Measured: Change from baseline at 6 months and 12 months

  8. Incidence of falls during one year

    Measured: through the study completion, an average of 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2016 (estimated)
  2. Study startOct 2014
  3. Primary completionJan 2021
  4. Study completionJan 2021

Why it stopped: Difficulties encountered in recruiting patients

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02862379
Sponsor's protocol ID
RC-P0034
Acronym
CHUTE
Status last verified
Jun 2026
First submitted
1 Aug 2016
Last updated
11 Jun 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing home-based program in people with Elderly and Falls, run by Lille Catholic University at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Difficulties encountered in recruiting patients). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Falls Efficacy Scale (FES-I) (time frame: Change from baseline at 6 months and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in